Loading organizations...
Affinity Capital Group operates as an integrated corporate finance and advisory house, providing specialized expertise across strategic advisory, mergers and acquisitions, private equity, and capital markets & financing. The firm offers tailored solutions, deeply engaging with clients on pivotal global themes like energy transition, food and water security, infrastructure, critical minerals, and indigenous engagement.
Established in 2022, Affinity Capital Group was founded by Adam Santa Maria, Demetrios Pynes, and Simon Tan. Their collective decades of experience in strategic financial guidance, capital markets, and complex merger and acquisition transactions informed the creation of this specialized advisory firm, enabling effective navigation of global economic challenges.
Affinity Capital Group serves diverse listed and unlisted companies, both within Australia and internationally. The company’s long-term vision centers on proactively driving significant change and fostering sustainable growth through its advisory services, guiding enterprises to capitalize on emerging opportunities within their core thematic areas.
Affinity Capital has 3 tracked investments across 3 companies. The latest tracked deal is $18.0M Series B in Uptake Medical in July 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2010 | Uptake Medical | $18.0M Series B | Eric J. KIM | Arboretum Ventures, FJ Labs, Founder Collective, Goodwater Capital, Illuminate Ventures, Perseverance Capital, Primary Venture Partners, Tekton Ventures, Michael Moritz, GBS Venture Partners, ONSET Ventures, WRF Capital |
| Jan 25, 2010 | Salient Surgical Technologies | $15.1M Series G | — | Arnerich Massena, Medtronic |
| Jun 15, 2009 | Anulex Technologies | $10.2M Series D | — | Delphi Ventures, MB Venture Partners, NEW Enterprise Associates, SightLine Partners, Split Rock Partners |